Ollitrault Pierre, Al Khoury Mayane, Troadec Yann, Calcagno Yoann, Champ-Rigot Laure, Ferchaud Virginie, Pellissier Arnaud, Legallois Damien, Milliez Paul, Labombarda Fabien
Department of Cardiology, Caen University Hospital, Caen-Normandy University, Caen, France.
Department of Genetics, Caen University Hospital, Caen-Normandy University, Caen, France.
Front Cardiovasc Med. 2022 Oct 28;9:998883. doi: 10.3389/fcvm.2022.998883. eCollection 2022.
Myocardial inflammation has been consistently associated with genetic arrhythmogenic cardiomyopathy (ACM) and it has been hypothesized that episodes mimicking acute myocarditis (AM) could represent early inflammatory phases of the disease.
We evaluated the temporal association between recurrent acute myocarditis (RAM) episodes and the later diagnosis of a genetic ACM.
Between January 2012 and December 2021, patients with RAM and no previous cardiomyopathy were included (Recurrent Acute Myocarditis Registry, NCT04589156). A follow-up visit including clinical evaluation, resting and stress electrocardiogram, cardiac magnetic resonance imaging, and genetic testing was carried out. Endpoints of the study was the incidence of both ACM diagnosis criteria and ACM genetic mutation at the end of follow-up.
Twenty-one patients with RAM were included and follow-up was completed in 19/21 patients (90%). At the end of follow-up, 3.3 ± 2.9 years after the last AM episode, 14/21 (67%) patients with an ACM phenotype (biventricular: 10/14, 71%; left ventricular: 4/14, 29%) underwent genetic testing. A pathogenic or likely pathogenic mutation was found in 8/14 patients (57%), 5/8 in the Desmoplakin gene, 2/8 in the Plakophillin-2 gene, and 1/8 in the Titin gene. Family history of cardiomyopathy or early sudden cardiac death had a positive predictive value of 88% for the presence of an underlying genetic mutation in patients with RAM.
RAM is a rare entity associated with the latter diagnosis of an ACM genetic mutation in more than a third of the cases. In those patients, RAM episodes represent early inflammatory phases of the disease. Including RAM episodes in ACM diagnosis criteria might allow early diagnosis and potential therapeutic interventions.
心肌炎症一直与遗传性致心律失常性心肌病(ACM)相关,并且据推测,类似急性心肌炎(AM)的发作可能代表该疾病的早期炎症阶段。
我们评估了复发性急性心肌炎(RAM)发作与遗传性ACM的后期诊断之间的时间关联。
纳入2012年1月至2021年12月期间患有RAM且既往无心肌病的患者(复发性急性心肌炎登记处,NCT04589156)。进行了包括临床评估、静息和负荷心电图、心脏磁共振成像以及基因检测在内的随访。研究终点是随访结束时ACM诊断标准和ACM基因突变的发生率。
纳入了21例RAM患者,19/21例患者(90%)完成了随访。随访结束时,即最后一次AM发作后3.3±2.9年,14/21例(67%)具有ACM表型的患者(双心室:10/14,71%;左心室:4/14,29%)接受了基因检测。在14/8例患者(57%)中发现了致病性或可能致病性突变,其中5/8在桥粒斑蛋白基因,2/8在盘状球蛋白2基因,1/8在肌联蛋白基因。心肌病家族史或早期心源性猝死对RAM患者潜在基因突变的存在具有88%的阳性预测价值。
RAM是一种罕见的疾病,超过三分之一的病例与ACM基因突变的后期诊断相关。在这些患者中,RAM发作代表该疾病的早期炎症阶段。将RAM发作纳入ACM诊断标准可能有助于早期诊断和潜在的治疗干预。